6523.TWO · DR.WU
Taiwan · RS rating 32 · As of 2026-10-08
| Price | 88.90 TWD |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 57 / 61 / 23 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 15 / 40 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -83.0% |
| Sales growth Q/Q | -26.6% |
| Distance from 52-week high | +29.4% |
| Market cap (USD) | $125.8M |